Global Newborn Screening Market Report and Forecast 2024-2032

1    Preface
    1.1    Objectives of the Study
    1.2    Key Assumptions
    1.3    Report Coverage – Key Segmentation and Scope
    1.4    Research Methodology
2    Executive Summary
3    Global Newborn Screening Market Overview 
    3.1    Global Newborn Screening Market Historical Value (2017-2023) 
    3.2    Global Newborn Screening Market Forecast Value (2024-2032)
4    Global Newborn Screening Market Landscape
    4.1    Global Newborn Screening Developers Landscape
        4.1.1    Analysis by Year of Establishment
        4.1.2    Analysis by Company Size
        4.1.3    Analysis by Region
    4.2    Global Newborn Screening Product Landscape
        4.2.1    Analysis by Product Type
        4.2.2    Analysis by Technology
        4.2.3    Analysis by End User
5    Global Newborn Screening Market Dynamics
    5.1    Market Drivers and Constraints
    5.2    SWOT Analysis
    5.3    Porter’s Five Forces Model 
    5.4    Key Demand Indicators
    5.5    Key Price Indicators
    5.6    Industry Events, Initiatives, and Trends 
    5.7    Value Chain Analysis
6    Global Newborn Screening Market Segmentation 
    6.1    Global Newborn Screening Market by Product Type
        6.1.1    Market Overview
        6.1.2    Instruments
        6.1.3    Reagent’s & Assay Kits
    6.2    Global Newborn Screening Market by Technology
        6.2.1    Market Overview
        6.2.2    Tandem Mass Spectrometry
        6.2.3    Pulse Oximetry
        6.2.4    Enzyme Based Assays
        6.2.5    DNA Assays
        6.2.6    Electrophoresis
        6.2.7    Others
    6.3    Global Newborn Screening Market by Test Type
        6.3.1    Market Overview
        6.3.2    Dry Blood Spot Test
        6.3.3    Critical Congenital Heart Disease (CCHD)
        6.3.4    Hearing Screen
        6.3.5    Others
    6.4    Global Newborn Screening Market by Diseases Type
        6.4.1    Market Overview
        6.4.2    Critical Congenital Heart Diseases
        6.4.3    New-born Hearing Loss
        6.4.4    Sickle Cell Disease
        6.4.5    Phenylketonuria (PKU)
        6.4.6    Cystic Fibrosis (CF)
        6.4.7    Maple Syrup Urine Disease
        6.4.8    Others
    6.5    Global Newborn Screening Market by End User
        6.5.1    Market Overview
        6.5.2    Clinical Laboratory
        6.5.3    Hospitals 
        6.5.4    Diagnostic Centre’s
        6.5.5    Others
    6.6    Global Newborn Screening Market by Region
        6.6.1    Market Overview
        6.6.2    North America 
        6.6.3    Europe
        6.6.4    Asia Pacific
        6.6.5    Latin America
        6.6.6    Middle East and Africa
7    North America Newborn Screening Market
    7.1    Market Share by Country
    7.2    United States of America
    7.3    Canada
8    Europe Newborn Screening Market
    8.1    Market Share by Country
    8.2    United Kingdom
    8.3    Germany
    8.4    France
    8.5    Italy
    8.6    Others
9    Asia Pacific Newborn Screening Market
    9.1    Market Share by Country
    9.2    China
    9.3    Japan
    9.4    India
    9.5    ASEAN
    9.6    Australia
    9.7    Others
10    Latin America Newborn Screening Market
    10.1    Market Share by Country
    10.2    Brazil
    10.3    Argentina
    10.4    Mexico
    10.5    Others
11    Middle East and Africa Newborn Screening Market
    11.1    Market Share by Country
    11.2    Saudi Arabia
    11.3    United Arab Emirates
    11.4    Nigeria
    11.5    South Africa
    11.6    Others
12    Patent Analysis
    12.1    Analysis by Type of Patent
    12.2    Analysis by Publication year
    12.3    Analysis by Issuing Authority
    12.4    Analysis by Patent Age
    12.5    Analysis by CPC Analysis
    12.6    Analysis by Patent Valuation 
    12.7    Analysis by Key Players
13    Grants Analysis
    13.1    Analysis by year
    13.2    Analysis by Amount Awarded
    13.3    Analysis by Issuing Authority
    13.4    Analysis by Grant Application
    13.5    Analysis by Funding Institute
    13.6    Analysis by NIH Departments
    13.7    Analysis by Recipient Organization 
14    Funding Analysis
    14.1    Analysis by Funding Instances
    14.2    Analysis by Type of Funding
    14.3    Analysis by Funding Amount
    14.4    Analysis by Leading Players
    14.5    Analysis by Leading Investors
    14.6    Analysis by Geography
15    Partnership and Collaborations Analysis
    15.1    Analysis by Partnership Instances
    15.2    Analysis by Type of Partnership
    15.3    Analysis by Leading Players
    15.4    Analysis by Geography
16    Supplier Landscape
    16.1    PerkinElmer Inc.
        16.1.1    Financial Analysis
        16.1.2    Product Portfolio
        16.1.3    Demographic Reach and Achievements
        16.1.4    Mergers and Acquisitions
        16.1.5    Certifications
    16.2    Demant A/S
        16.2.1    Financial Analysis
        16.2.2    Product Portfolio
        16.2.3    Demographic Reach and Achievements
        16.2.4    Mergers and Acquisitions
        16.2.5    Certifications
    16.3    Natus Medical Incorporated
        16.3.1    Financial Analysis
        16.3.2    Product Portfolio
        16.3.3    Demographic Reach and Achievements
        16.3.4    Mergers and Acquisitions
        16.3.5    Certifications
    16.4    Bio-Rad Laboratories
        16.4.1    Financial Analysis
        16.4.2    Product Portfolio
        16.4.3    Demographic Reach and Achievements
        16.4.4    Mergers and Acquisitions
        16.4.5    Certifications
    16.5    Luminex Corporation
        16.5.1    Financial Analysis
        16.5.2    Product Portfolio
        16.5.3    Demographic Reach and Achievements
        16.5.4    Mergers and Acquisitions
        16.5.5    Certifications
    16.6    F. Hoffmann-La Roche Ltd.
        16.6.1    Financial Analysis
        16.6.2    Product Portfolio
        16.6.3    Demographic Reach and Achievements
        16.6.4    Mergers and Acquisitions
        16.6.5    Certifications
    16.7    Thermo Fisher Scientific Inc.
        16.7.1    Financial Analysis
        16.7.2    Product Portfolio
        16.7.3    Demographic Reach and Achievements
        16.7.4    Mergers and Acquisitions
        16.7.5    Certifications
    16.8    Bruker
        16.8.1    Financial Analysis
        16.8.2    Product Portfolio
        16.8.3    Demographic Reach and Achievements
        16.8.4    Mergers and Acquisitions
        16.8.5    Certifications
    16.9    Danaher
        16.9.1    Financial Analysis
        16.9.2    Product Portfolio
        16.9.3    Demographic Reach and Achievements
        16.9.4    Mergers and Acquisitions
        16.9.5    Certifications
    16.10    Medtronic
        16.10.1    Financial Analysis
        16.10.2    Product Portfolio
        16.10.3    Demographic Reach and Achievements
        16.10.4    Mergers and Acquisitions
        16.10.5    Certifications
    16.11    Chromsystems Instruments & Chemicals GmbH
        16.11.1    Financial Analysis
        16.11.2    Product Portfolio
        16.11.3    Demographic Reach and Achievements
        16.11.4    Mergers and Acquisitions
        16.11.5    Certifications
    16.12     Trivitron Healthcare
        16.12.1    Financial Analysis
        16.12.2    Product Portfolio
        16.12.3    Demographic Reach and Achievements
        16.12.4    Mergers and Acquisitions
        16.12.5    Certifications
    16.13     Baebies Inc
        16.13.1    Financial Analysis
        16.13.2    Product Portfolio
        16.13.3    Demographic Reach and Achievements
        16.13.4    Mergers and Acquisitions
        16.13.5    Certifications
17    Global Newborn Screening Market - Distribution Model (Additional Insight)
    17.1    Overview 
    17.2    Potential Distributors 
    17.3    Key Parameters for Distribution Partner Assessment 
18    Key Opinion Leaders (KOL) Insights (Additional Insight)
19    Company Competitiveness Analysis (Additional Insight)
    19.1    Very Small Companies
    19.2    Small Companies
    19.3    Mid-Sized Companies
    19.4    Large Companies
    19.5    Very Large Companies
20    Payment Methods (Additional Insight)
    20.1    Government Funded
    20.2    Private Insurance
    20.3    Out-of-Pocket

*Additional insights provided are customisable as per client requirements.